The Bleeding With Antithrombotic Therapy Study 2 (BAT2)
Sponsor: Japan Agency for Medical Research and Development
Listed as NCT02889653, this observational or N/A phase trial focuses on Cerebrovascular and Cardiovascular Diseases and remains completed. Sponsored by Japan Agency for Medical Research and Development, it has been updated 11 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Nov 2023 — Dec 2023 [monthly]
Unknown Status
-
Apr 2022 — Nov 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
-
Jun 2018 — Jan 2021 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Japan Agency for Medical Research and Development
- National Cerebral and Cardiovascular Center, Japan
For direct contact, visit the study record on ClinicalTrials.gov .